List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1121 studies with search of:   "Paclitaxel"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: PF-3512676 + Paclitaxel + Carboplatin;   Drug: Paclitaxel + Carboplatin
2 Terminated Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: paclitaxel + carboplatin + bevacizumab;   Drug: carboplatin + paclitaxel + bevacizumab + PF-3512676
3 Recruiting A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Sunitinib;   Drug: paclitaxel;   Drug: bevacizumab;   Drug: paclitaxel
4 Active, not recruiting Study of Dose-Dense Adriamycin Plus Cytoxan (AC) Followed by Either Abraxane or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Cytoxan;   Drug: Neulasta;   Drug: Bevacizumab;   Drug: ABI-007;   Drug: Taxol;   Drug: Adriamycin;   Drug: ABI-007 plus Bevacizumab;   Drug: ABI-007 plus Bevacizuman;   Drug: ABI-007 plus Bevacizumag;   Drug: ABI-007 plus Bevacizumab
5 Active, not recruiting Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
Condition: Coronary Restenosis
Interventions: Drug: ABI-007;   Drug: ABI-007;   Drug: ABI-007;   Drug: ABI-007
6 Active, not recruiting Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer
Condition: Neoplasm
Interventions: Drug: Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU);   Drug: Paclitaxel for injection (Taxol)
7 Recruiting A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
Conditions: Non-Small Cell Lung Cancer;   Malignant Pleural Effusions
Interventions: Drug: Cetuximab + Bevacizumab + Paclitaxel + Carboplatin (6/6);   Drug: Cetuximab + Bevacizumab + Paclitaxel + Carboplatin (6/3)
8 Recruiting Pharmacokinetics Study of Liposomal Paclitaxel in Humans
Condition: Cancer
Interventions: Drug: Liposomal paclitaxel;   Drug: Paclitaxel
9 Recruiting PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Tubal Cancer
Intervention: Drug: Dasatinib, Paclitaxel, and Carboplatin
10 Recruiting Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head & Neck Cancer
Intervention: Other: Cetuximab, IMRT, Albumin-bound paclitaxel (Abraxane®)
11 Recruiting Hepatic Arterial Infusion (HAI) of Abraxane
Conditions: Liver Cancer;   Advanced Cancers;   Solid Tumors
Interventions: Drug: Abraxane;   Procedure: Hepatic Artery Catheter
12 Recruiting A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.
Conditions: Non-Small-Cell Lung Carcinoma;   Adenocarcinoma
Interventions: Drug: Bevacizumab + Carboplatin + Paclitaxel;   Drug: AG-013736 (axitinib) + Carboplatin + Paclitaxel
13 Recruiting Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
Conditions: Metastatic Breast Cancer;   First or Second Line Therapy
Intervention: Drug: Lapatinib/nab-Paclitaxel
14 Not yet recruiting Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Paclitaxel
15 Recruiting Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: 5-Fluorouracil;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: RAD001
16 Recruiting Abraxane and Temodar Plus Genasense in Advanced Melanoma
Condition: Melanoma
Interventions: Drug: Genasense® (oblimersen);   Drug: Abraxane® (paclitaxel protein-bound particles for injectable suspension);   Drug: Temodar® (temozolomide)
17 Recruiting Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Interventions: Drug: combretastatin A-4 phosphate (CA4P);   Drug: paclitaxel;   Drug: carboplatin
18 Recruiting PEPCAD IV, Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients
Conditions: Coronary Stenosis;   Diabetes Mellitus
Interventions: Device: Paclitaxel Eluting Balloon;   Device: paclitaxel eluting stent
19 Active, not recruiting A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer
Conditions: Carcinoma;   Non-Squamous Non-Small-Cell Lung
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: CDP791 10mg/kg;   Drug: CDP791 20mg/kg
20 Active, not recruiting Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: paclitaxel;   Drug: paclitaxel albumin-stabilized nanoparticle formulation

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services